HUP9900873A3 - Dna sequence and encoded mammary-specific breast cancer protein - Google Patents

Dna sequence and encoded mammary-specific breast cancer protein

Info

Publication number: HUP9900873A3
Authority: HU; Hungary
Prior art keywords: breast cancer; dna sequence; cancer protein; specific breast; mammary
Prior art date: 1995-05-31

Application number

HU9900873A

Other languages

English (en)

Original Assignee

Univ St Louis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-05-31

Filing date

1996-05-31

Publication date

1999-11-29

1996-05-31 Application filed by Univ St Louis filed Critical Univ St Louis

1999-07-28 Publication of HUP9900873A2 publication Critical patent/HUP9900873A2/hu

1999-11-29 Publication of HUP9900873A3 publication Critical patent/HUP9900873A3/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
- G01N33/57515—
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Pathology (AREA)
Analytical Chemistry (AREA)
Biophysics (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Hospice & Palliative Care (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Physics & Mathematics (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

HU9900873A 1995-05-31 1996-05-31 Dna sequence and encoded mammary-specific breast cancer protein HUP9900873A3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/455,896 US5668267A (en)	1995-05-31	1995-05-31	Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein

Publications (2)

Publication Number	Publication Date
HUP9900873A2 HUP9900873A2 (hu)	1999-07-28
HUP9900873A3 true HUP9900873A3 (en)	1999-11-29

Family

ID=23810680

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU9900873A HUP9900873A3 (en)	1995-05-31	1996-05-31	Dna sequence and encoded mammary-specific breast cancer protein

Country Status (22)

Country	Link
US (5)	US5668267A (hu)
EP (1)	EP0833834B1 (hu)
JP (2)	JP3949165B2 (hu)
KR (1)	KR19990022122A (hu)
CN (1)	CN1279051C (hu)
AT (1)	ATE190313T1 (hu)
AU (1)	AU698823B2 (hu)
BR (1)	BR9609270A (hu)
CA (2)	CA2741641C (hu)
CZ (1)	CZ378397A3 (hu)
DE (1)	DE69607001T2 (hu)
DK (1)	DK0833834T3 (hu)
EA (1)	EA001398B1 (hu)
ES (1)	ES2145451T3 (hu)
GR (1)	GR3033636T3 (hu)
HU (1)	HUP9900873A3 (hu)
NO (1)	NO975508L (hu)
NZ (1)	NZ309445A (hu)
PL (1)	PL323632A1 (hu)
PT (1)	PT833834E (hu)
TR (1)	TR199701462T1 (hu)
WO (1)	WO1996038463A1 (hu)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5668267A (en) *	1995-05-31	1997-09-16	Washington University	Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
US5922836A (en) *	1995-05-31	1999-07-13	Washington University	Mammaglobin antigens
US6566072B1 (en)	1995-05-31	2003-05-20	Washington University	Mammaglobin, a secreted mammary-specific breast cancer protein
US6344550B1 (en)	1996-01-11	2002-02-05	Corixa Corporation	Compositions and methods for the treatment and diagnosis of breast cancer
US6861506B1 (en)	1996-01-11	2005-03-01	Corixa Corporation	Compositions and methods for the treatment and diagnosis of breast cancer
US6225054B1 (en)	1996-01-11	2001-05-01	Corixa Corporation	Compositions and methods for the treatment and diagnosis of breast cancer
US6586570B1 (en)	1996-01-11	2003-07-01	Corixa Corporation	Compositions and methods for the treatment and diagnosis of breast cancer
US6828431B1 (en)	1999-04-09	2004-12-07	Corixa Corporation	Compositions and methods for the therapy and diagnosis of breast cancer
US6423496B1 (en)	1996-01-11	2002-07-23	Corixa Corporation	Compositions and methods for the treatment and diagnosis of breast cancer
US6656480B2 (en)	1996-01-11	2003-12-02	Corixa Corporation	Compositions and methods for the treatment and diagnosis of breast cancer
US7241876B2 (en)	1996-01-11	2007-07-10	Corixa Corporation	Compositions and methods for the therapy and diagnosis of breast cancer
AU5367996A (en) *	1996-03-21	1997-10-10	Human Genome Sciences, Inc.	Human endometrial specific steroid-binding factor i, ii and iii
US6174992B1 (en)	1997-03-21	2001-01-16	Human Genome Sciences, Inc.	Human endometrial specific steroid-binding factor I, II and III
US6552164B1 (en)	1996-08-19	2003-04-22	Abbott Laboratories	Reagents and methods useful for detecting diseases of the breast
US6379671B1 (en)	1996-08-19	2002-04-30	Abbott Laboratories	Reagents and methods useful for detecting diseases of the breast
US7282207B1 (en)	1996-08-19	2007-10-16	Abbott Laboratories	Reagents and methods useful for detecting diseases of the reproductive tissues
US20030044859A1 (en) *	1996-08-19	2003-03-06	Henslee Jerry G.	Reagents and methods useful for detecting diseases of the breast
WO1998007753A1 (en) *	1996-08-19	1998-02-26	Abbott Laboratories	Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast
US6770435B1 (en)	1996-08-19	2004-08-03	Abbott Laboratories	Reagents and methods useful for detecting diseases of the breast
AU7180198A (en) *	1996-11-12	1998-06-03	Incyte Pharmaceuticals, Inc.	Human breast tumor-specific proteins
ZA982968B (en) *	1997-04-09	1998-10-27	Corixa Corp	Compositions and methods for the treatment and diagnosis of breast cancer
US6667291B2 (en)	1997-06-09	2003-12-23	Smithkline Beecham Corporation	Method of detecting and treating cancer
EP1002132A4 (en) *	1997-08-05	2005-04-27	Human Genome Sciences Inc	HUMAN SECRETED PROTEINS
EP1023443A1 (en) *	1997-10-16	2000-08-02	Incyte Pharmaceuticals, Inc.	Mammoglobin homolog
EP1032706A1 (en) *	1997-11-18	2000-09-06	Abbott Laboratories	Reagents and methods useful for detecting diseases of the breast
US20040033230A1 (en) *	1997-12-24	2004-02-19	Corixa Corporation	Compositions and methods for the therapy and diagnosis of breast cancer
US20020045165A1 (en) *	1997-12-26	2002-04-18	Patricia A. Billing-Medel	Reagents and methods useful for detecting diseases of the breast
AU2342299A (en) *	1998-01-26	1999-08-09	Genquest Inc.	Compositions and methods for detecting and treating breast cancer
DE19813839A1 (de) *	1998-03-20	1999-09-23	Metagen Gesellschaft Fuer Genomforschung Mbh	Menschliche Nukleinsäuresequenzen aus Brusttumorgewebe
US6737040B1 (en)	1998-08-04	2004-05-18	Diadexus, Inc.	Method and antibody for imaging breast cancer
CA2347906A1 (en) *	1998-08-04	2000-02-17	Diadexus, Inc.	A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
US6730477B1 (en) *	1998-08-04	2004-05-04	Diadexus, Inc.	Method of diagnosing, monitoring and staging breast cancer
EP1169066A4 (en) *	1998-10-02	2002-10-30	Diadexus Inc	METHOD FOR DIAGNOSTICS, MONITORING, STAGE DETECTION, IMAGING AND TREATMENT OF GYNAECOLOGICAL CANCER
US7014996B1 (en)	1998-10-02	2006-03-21	Diadexus, Inc.	Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers
US6969518B2 (en) *	1998-12-28	2005-11-29	Corixa Corporation	Compositions and methods for the therapy and diagnosis of breast cancer
US6958361B2 (en) *	1998-12-28	2005-10-25	Corixa Corporation	Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) *	1998-12-28	2009-10-06	Corixa Corporation	Compositions and methods for the therapy and diagnosis of breast cancer
US6680197B2 (en)	1998-12-28	2004-01-20	Corixa Corporation	Compositions and methods for the therapy and diagnosis of breast cancer
US6528054B1 (en)	1998-12-28	2003-03-04	Corixa Corporation	Compositions and methods for the therapy and diagnosis of breast cancer
US6517513B1 (en) *	1999-01-21	2003-02-11	Neomatrix, Llc	Intraductal breast fluid aspiration device
US20030045468A1 (en) *	1999-05-28	2003-03-06	Corixa Corporation	Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
EP1185557A1 (en) *	1999-05-28	2002-03-13	Corixa Corporation	Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
US6416956B1 (en)	1999-08-13	2002-07-09	George Washington University	Transcription factor, BP1
US20040018570A1 (en) *	1999-09-01	2004-01-29	Brown University	Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth
CA2392510A1 (en) *	1999-11-30	2001-06-07	Corixa Corporation	Compositions and methods for therapy and diagnosis of breast cancer
AU2002213084A1 (en) *	2000-10-11	2002-04-22	Avalon Pharmaceuticals	Cancer-linked genes as targets for chemotherapy
PT1326638E (pt)	2000-10-18	2008-02-06	Glaxosmithkline Biolog Sa	Vacinas contra cancros
GB0109297D0 (en)	2001-04-12	2001-05-30	Glaxosmithkline Biolog Sa	Vaccine
US20030073951A1 (en) *	2001-05-30	2003-04-17	Morton Kevin B.	Disposable patient interface for intraductal fluid aspiration system
US6866994B2 (en)	2001-05-30	2005-03-15	Neomatrix, Llc	Noninvasive intraductal fluid diagnostic screen
WO2003076896A2 (en) *	2002-03-06	2003-09-18	Johns Hopkins University	Use of biomarkers to detect breast cancer
US20050186577A1 (en) *	2004-02-20	2005-08-25	Yixin Wang	Breast cancer prognostics
US7981616B2 (en) *	2004-02-27	2011-07-19	Musc Foundation For Research Development	Enhanced detection of RNA using a panel of truncated gene-specific primers for reverse transcription
CA2623775A1 (en)	2005-09-19	2007-03-29	Veridex, Llc	Methods and materials for identifying the origin of a carcinoma of unknown primary origin
TWI457133B (zh)	2005-12-13	2014-10-21	Glaxosmithkline Biolog Sa	新穎組合物
EP2491116A4 (en) *	2009-10-22	2013-12-11	Univ Jefferson	CELL-BASED ANTI-CANCER COMPOSITIONS AND METHODS OF MAKING AND USING SAME
CN101974088B (zh) *	2010-11-03	2014-04-02	中国人民解放军军事医学科学院基础医学研究所	乳腺珠蛋白单克隆抗体及其在乳腺癌诊断中的应用
US8808373B2 (en)	2012-06-13	2014-08-19	Elwha Llc	Breast implant with regionalized analyte sensors responsive to external power source
US9144488B2 (en)	2012-06-13	2015-09-29	Elwha Llc	Breast implant with analyte sensors responsive to external power source
US9211185B2 (en)	2012-06-13	2015-12-15	Elwha Llc	Breast implant with analyte sensors and internal power source
US9144489B2 (en)	2012-06-13	2015-09-29	Elwha Llc	Breast implant with covering, analyte sensors and internal power source
US8790400B2 (en)	2012-06-13	2014-07-29	Elwha Llc	Breast implant with covering and analyte sensors responsive to external power source
US8795359B2 (en)	2012-06-13	2014-08-05	Elwha Llc	Breast implant with regionalized analyte sensors and internal power source
KR102499664B1 (ko) *	2020-02-27	2023-02-15	주식회사 베르티스	암의 진단용 조성물
KR102499678B1 (ko) *	2020-02-27	2023-02-15	주식회사 베르티스	암의 진단용 조성물
KR102433983B1 (ko) *	2020-02-27	2022-08-23	주식회사 베르티스	암의 진단용 조성물
WO2021172923A1 (ko) *	2020-02-27	2021-09-02	㈜베르티스	암의 진단용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5298399A (en) *	1990-08-10	1994-03-29	Sapporo Breweries Limited	Gene and process for producing a thermostable urease
US5593972A (en)	1993-01-26	1997-01-14	The Wistar Institute	Genetic immunization
US5610031A (en)	1993-10-27	1997-03-11	The General Hospital Corporation	B1k chain of laminin and methods of use
US5573916A (en)	1994-05-19	1996-11-12	Coretech, Inc.	Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
US5668267A (en)	1995-05-31	1997-09-16	Washington University	Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
US5922836A (en) *	1995-05-31	1999-07-13	Washington University	Mammaglobin antigens

1995
- 1995-05-31 US US08/455,896 patent/US5668267A/en not_active Expired - Lifetime
1996
- 1996-05-31 KR KR1019970708601A patent/KR19990022122A/ko not_active Abandoned
- 1996-05-31 BR BR9609270A patent/BR9609270A/pt not_active Application Discontinuation
- 1996-05-31 CA CA2741641A patent/CA2741641C/en not_active Expired - Lifetime
- 1996-05-31 DK DK96916892T patent/DK0833834T3/da active
- 1996-05-31 PL PL96323632A patent/PL323632A1/xx unknown
- 1996-05-31 TR TR97/01462T patent/TR199701462T1/xx unknown
- 1996-05-31 EP EP96916892A patent/EP0833834B1/en not_active Expired - Lifetime
- 1996-05-31 WO PCT/US1996/008235 patent/WO1996038463A1/en not_active Ceased
- 1996-05-31 CZ CZ973783A patent/CZ378397A3/cs unknown
- 1996-05-31 DE DE69607001T patent/DE69607001T2/de not_active Expired - Lifetime
- 1996-05-31 CN CNB961952725A patent/CN1279051C/zh not_active Expired - Lifetime
- 1996-05-31 JP JP53673496A patent/JP3949165B2/ja not_active Expired - Lifetime
- 1996-05-31 PT PT96916892T patent/PT833834E/pt unknown
- 1996-05-31 HU HU9900873A patent/HUP9900873A3/hu unknown
- 1996-05-31 AT AT96916892T patent/ATE190313T1/de active
- 1996-05-31 EA EA199700447A patent/EA001398B1/ru not_active IP Right Cessation
- 1996-05-31 AU AU59616/96A patent/AU698823B2/en not_active Expired
- 1996-05-31 NZ NZ309445A patent/NZ309445A/xx not_active IP Right Cessation
- 1996-05-31 CA CA2222747A patent/CA2222747C/en not_active Expired - Lifetime
- 1996-05-31 ES ES96916892T patent/ES2145451T3/es not_active Expired - Lifetime
- 1996-09-30 US US08/722,304 patent/US5855889A/en not_active Expired - Lifetime
1997
- 1997-11-28 NO NO975508A patent/NO975508L/no not_active Application Discontinuation
1998
- 1998-05-20 US US09/082,253 patent/US6004756A/en not_active Expired - Lifetime
- 1998-05-20 US US09/082,343 patent/US5968754A/en not_active Expired - Lifetime
1999
- 1999-03-25 US US09/509,015 patent/US6677428B1/en not_active Expired - Lifetime
2000
- 2000-06-08 GR GR20000401323T patent/GR3033636T3/el unknown
2007
- 2007-01-31 JP JP2007021666A patent/JP3989528B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NO975508L (no)	1998-03-18
PL323632A1 (en)	1998-04-14
CA2222747C (en)	2011-06-28
CA2222747A1 (en)	1996-12-05
CA2741641C (en)	2014-08-05
CN1279051C (zh)	2006-10-11
HUP9900873A2 (hu)	1999-07-28
AU5961696A (en)	1996-12-18
US5855889A (en)	1999-01-05
MX9709364A (es)	1998-08-30
JP3949165B2 (ja)	2007-07-25
DE69607001T2 (de)	2000-11-02
DE69607001D1 (de)	2000-04-13
KR19990022122A (ko)	1999-03-25
ES2145451T3 (es)	2000-07-01
DK0833834T3 (da)	2000-07-31
NZ309445A (en)	1999-11-29
ATE190313T1 (de)	2000-03-15
AU698823B2 (en)	1998-11-05
TR199701462T1 (xx)	1998-04-21
JPH11507212A (ja)	1999-06-29
US6677428B1 (en)	2004-01-13
EA199700447A1 (ru)	1998-08-27
JP3989528B2 (ja)	2007-10-10
PT833834E (pt)	2000-08-31
GR3033636T3 (en)	2000-10-31
CN1189836A (zh)	1998-08-05
JP2007145855A (ja)	2007-06-14
US6004756A (en)	1999-12-21
NO975508D0 (no)	1997-11-28
US5668267A (en)	1997-09-16
EP0833834B1 (en)	2000-03-08
EP0833834A1 (en)	1998-04-08
CZ378397A3 (cs)	1998-06-17
US5968754A (en)	1999-10-19
EA001398B1 (ru)	2001-02-26
BR9609270A (pt)	1999-05-11
EP0833834A4 (en)	1998-06-03
WO1996038463A1 (en)	1996-12-05
CA2741641A1 (en)	1996-12-05

Publication	Publication Date	Title
HUP9900873A3 (en)	1999-11-29	Dna sequence and encoded mammary-specific breast cancer protein
ZA979096B (en)	1998-08-28	Viral and cancer treatment
PT1818343E (pt)	2012-07-12	Anticorpos contra a il-12 humana
IL106278A0 (en)	1993-11-15	Bone formation-inducing protein
GB9310472D0 (en)	1993-07-07	Phenylalanine-free protein and dna coding thereof
EP0911397A4 (en)	2002-10-09	TUMORANTANT PROTEINS, THEIR GENES, AND TUMORANTANT PEPTIDES
EP0851869A4 (en)	2002-08-14	GENES AND PROTEINS SPECIFIC TO THE BREAST
HUP9700676A3 (en)	2001-02-28	Anti-fas recombinante antibodies and dna coding thereof
GB9303210D0 (en)	1993-03-31	Cancer treatment
GB9419021D0 (en)	1994-11-09	Therapeutic protein
GB9509572D0 (en)	1995-07-05	Cancer therapy
EP1141002A4 (en)	2005-08-24	HUMAN PROTOONCOGEN OF COLUMN 1 CANCER AND PROTEIN CODED THEREIN
EP1012262A4 (en)	2002-11-06	HFLP PROTEIN HFLP
ZA964821B (en)	1997-02-11	Bone stimulating factor.
GB9421093D0 (en)	1994-12-07	Hippocampus-associated proteins, DNA sequences coding therefore and uses thereof
MD798F1 (en)	1997-08-31	Method of the mamma cancer treatment
EP0729975A4 (en)	2002-09-25	PROTEIN ECDN AND DNA ENCODING THIS PROTEIN
GB9620350D0 (en)	1996-11-13	Cancer vaccine
GB9703633D0 (en)	1997-04-09	Cancer therapy
GB9519865D0 (en)	1995-11-29	Protein
AU4068897A (en)	1998-03-06	Human induced tumor protein
GB9824357D0 (en)	1998-12-30	Protein and DNA coding therefor
GB9613629D0 (en)	1996-08-28	Reg gene expression in cancer tissue
EP1142999A4 (en)	2002-08-28	PROTEIN AND ITS DNA
GB9622436D0 (en)	1997-01-08	Protein